Acceleron Pharma reported $25.21M in Trade Debtors for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acceleron Pharma XLRN:US $ 25.21M 0.89M
Akebia Therapeutics AKBA:US $ 35.23M 8.38M
Alexion Pharmaceuticals ALXN:US $ 1473M 63.7M
Amgen AMGN:US $ 4423M 102M
Bayer BAYN:GR 15.89B 3.44B
Biomarin Pharmaceutical BMRN:US $ 424.42M 28.32M
Bluebird Bio BLUE:US $ 0M 0.4M
Clovis Oncology CLVS:US $ 26.44M 4.16M
Dicerna Pharmaceuticals DRNA:US $ 31.27M 4.79M
Eli Lilly And LLY:US $ 6658.6M 270.4M
Exelixis EXEL:US $ 177.67M 16.8M
Gilead Sciences GILD:US $ 4149M 224M
GlaxoSmithKline GSK:LN 7.51B 324M
Karyopharm Therapeutics KPTI:US $ 17.84M 4.96M
Mirati Therapeutics MRTX:US $ 1.84M 0.47M
Neurocrine Biosciences NBIX:US $ 147.8M 9.3M
Novartis NOVN:VX 8.48B 25M
Ptc Therapeutics PTCT:US $ 78.8M 15.32M
Puma Biotechnology PBYI:US $ 26.16M 2.76M
Regeneron Pharmaceuticals REGN:US $ 4173M 58.3M
Rigel Pharmaceuticals RIGL:US $ 142.2M 126.22M
Sangamo Biosciences SGMO:US $ 7.72M 1.46M
United Therapeutics UTHR:US $ 141.1M 16.3M
Vertex Pharmaceuticals VRTX:US $ 929.14M 48.41M